### BEGIN COMPANY REPORT
Company: Idexx Laboratories  
Sector: Health Care  
Industry: Health Care Equipment

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 4/5
- Dimension 2 (Data Infrastructure and Analytics): 4/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 4/5
- Dimension 4 (Human Capital and AI Skills): 3/5
- Dimension 5 (AI Governance and Responsible Implementation): 3/5

**Overall AI-Readiness Score:** 3.85/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Several of these in-clinic analyzers, including the Catalyst One Chemistry analyzer, ProCyte One hematology analyzer, SediVue Dx Analyzer, and IDEXX inVue Dx Cellular Analyzer, utilize proprietary artificial intelligence (“AI”) capabilities in their image capture systems to analyze samples."
- **Dimension 2 Evidence:** "IDEXX DecisionIQ, an analytical tool incorporated in VetConnect PLUS that utilizes proprietary technology, including AI, to aid practitioners in making medical diagnoses."
- **Dimension 3 Evidence:** "IDEXX Telemedicine services are accessed through IDEXX VetMedStat, a cloud-based software platform for case submission and interpretation that embeds proprietary AI capabilities."
- **Dimension 4 Evidence:** No specific mention of AI/ML talent acquisition or training programs in the excerpts.
- **Dimension 5 Evidence:** "Our products that use generative or other forms of artificial intelligence may also be subject to new and emerging law and regulations, including the European Union’s Artificial Intelligence Act enacted in August 2024."

**Strategic AI Positioning:** AI is integral to Idexx Laboratories' diagnostic products and services, providing significant competitive advantages in veterinary healthcare through enhanced diagnostic capabilities and customer insights.

**Contextual Considerations:** The company's focus on AI in diagnostics aligns with its position in the health care equipment sector, where innovation is crucial for maintaining competitive advantage.

**Confidence Level:** High - based on the specificity and depth of AI-related disclosures in the report excerpts.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Illinois Tool Works  
Sector: Industrials  
Industry: Industrial Machinery & Supplies & Components

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 2/5
- Dimension 2 (Data Infrastructure and Analytics): 2/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 2/5
- Dimension 4 (Human Capital and AI Skills): 2/5
- Dimension 5 (AI Governance and Responsible Implementation): 2/5

**Overall AI-Readiness Score:** 2.00/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Difficulties or delays in research, development, production or commercialization of new products and services or in the adoption of technological change, such as the use of artificial intelligence and machine learning, may reduce future revenues and adversely affect the Company's competitive position."
- **Dimension 2 Evidence:** No specific evidence on advanced data infrastructure or analytics capabilities.
- **Dimension 3 Evidence:** No specific evidence on modern technology infrastructure or cloud adoption.
- **Dimension 4 Evidence:** No specific mention of AI/ML talent acquisition or training programs in the excerpts.
- **Dimension 5 Evidence:** "The Company may incur fines or penalties, damage to its reputation or other adverse consequences if its employees, agents or business partners violate... artificial intelligence... laws."

**Strategic AI Positioning:** AI is acknowledged as a potential area of technological change, but there is limited evidence of strategic integration or significant investment in AI capabilities.

**Contextual Considerations:** As an industrial machinery company, the focus may be more on traditional manufacturing processes, with AI adoption still in nascent stages.

**Confidence Level:** Medium - based on limited AI-related disclosures in the report excerpts.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Incyte  
Sector: Health Care  
Industry: Biotechnology

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 3/5
- Dimension 2 (Data Infrastructure and Analytics): 3/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 3/5
- Dimension 4 (Human Capital and AI Skills): 2/5
- Dimension 5 (AI Governance and Responsible Implementation): 2/5

**Overall AI-Readiness Score:** 2.85/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Additionally, the use of artificial intelligence based software is increasing in the biopharmaceutical industry."
- **Dimension 2 Evidence:** No specific evidence on advanced data infrastructure or analytics capabilities.
- **Dimension 3 Evidence:** No specific evidence on modern technology infrastructure or cloud adoption.
- **Dimension 4 Evidence:** No specific mention of AI/ML talent acquisition or training programs in the excerpts.
- **Dimension 5 Evidence:** "Use of artificial intelligence based software may also lead to the release of confidential proprietary information, which may impact our ability to realize the benefit of our intellectual property."

**Strategic AI Positioning:** AI is being increasingly used in the biopharmaceutical industry, which suggests a developing role in Incyte's operations, particularly in drug discovery and development.

**Contextual Considerations:** The company's focus on drug discovery and development may drive AI adoption, but current integration appears to be in early stages.

**Confidence Level:** Medium - based on limited AI-related disclosures in the report excerpts.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Ingersoll Rand  
Sector: Industrials  
Industry: Industrial Machinery & Supplies & Components

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 3/5
- Dimension 2 (Data Infrastructure and Analytics): 2/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 3/5
- Dimension 4 (Human Capital and AI Skills): 2/5
- Dimension 5 (AI Governance and Responsible Implementation): 2/5

**Overall AI-Readiness Score:** 2.75/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "We have begun incorporating AI into our business activities and our product and service offerings."
- **Dimension 2 Evidence:** No specific evidence on advanced data infrastructure or analytics capabilities.
- **Dimension 3 Evidence:** "Robotics Our automated liquid handling products, which includes syringe pumps and accessories, are integrated into large-scale, automated liquid handling systems."
- **Dimension 4 Evidence:** No specific mention of AI/ML talent acquisition or training programs in the excerpts.
- **Dimension 5 Evidence:** "The development, adoption, and use of AI technologies are still in their early stages and ineffective or inadequate AI development or deployment practices could result in unintended consequences."

**Strategic AI Positioning:** AI is being incorporated into Ingersoll Rand's business activities and product offerings, indicating a growing strategic importance, though still in early stages.

**Contextual Considerations:** As an industrial machinery company, the integration of AI is likely focused on enhancing product offerings and operational efficiency.

**Confidence Level:** Medium - based on limited AI-related disclosures in the report excerpts.

### END COMPANY REPORT